Stay updated on ABX196+Nivolumab in Hepatocellular Carcinoma Clinical Trial

Sign up to get notified when there's something new on the ABX196+Nivolumab in Hepatocellular Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ABX196+Nivolumab in Hepatocellular Carcinoma Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    Added Hepatocellular carcinoma as a study condition and a Genetic and Rare Diseases Information Center resource link. The page revision updated from v3.4.3 to v3.5.0.
    Difference
    0.2%
    Check dated 2026-03-19T22:15:50.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-12T20:01:53.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    Minor UI/layout adjustments and an updated timestamp; no substantive changes to core study content such as eligibility, primary outcomes, or treatment details.
    Difference
    0.1%
    Check dated 2026-03-05T14:40:03.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    A new Revision: v3.4.2 is now visible. The funding lapse notice and the older Revision: v3.4.1 have been removed.
    Difference
    0.5%
    Check dated 2026-02-11T09:52:36.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    A site-wide notice about a lapse in government funding was added at the top, indicating information may not be up to date, and the page version was updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-04T06:43:09.000Z thumbnail image
  8. Check
    68 days ago
    Change Detected
    Summary
    These changes are administrative UI and metadata updates (Show glossary; Last Update Submitted that Met QC Criteria; No FEAR Act Data; Revision: v3.4.0) with the removal of similar prior items (Last Update Submitted that met QC Criteria; No FEAR Act data; Revision: v3.3.4); they do not modify core study content, and to avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T04:39:30.000Z thumbnail image

Stay in the know with updates to ABX196+Nivolumab in Hepatocellular Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ABX196+Nivolumab in Hepatocellular Carcinoma Clinical Trial page.